Target Gene/Pathway
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z other
| No. | KEGG PATHWAY * On map, Yellow: Drug target, Red: Disease-related |
KEGG GENES * [Number of genes] |
KEGG DRUG * | DrugBank | Disease ID * [Number of diseases] |
| 1 | Adipocytokine signaling pathway |
[1] TNF | D04687 | Lenalidomide | [8] 16, 26, 28, 34, 49, 96, 284, 300 |
| 2 | African trypanosomiasis |
[1] TNF | D04687 | Lenalidomide | [8] 16, 26, 28, 34, 49, 96, 284, 300 |
| 3 | AGE-RAGE signaling pathway in diabetic complications |
[1] TNF | D04687 | Lenalidomide | [8] 16, 26, 28, 34, 49, 96, 284, 300 |
| 4 | Allograft rejection |
[2] CD80, CD86 | D03203 | Abatacept | [24] 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
| [1] TNF | D04687 | Lenalidomide | [8] 16, 26, 28, 34, 49, 96, 284, 300 | ||
| 5 | Alzheimer disease |
[1] TNF | D04687 | Lenalidomide | [8] 16, 26, 28, 34, 49, 96, 284, 300 |
| 6 | Amoebiasis |
[1] TNF | D04687 | Lenalidomide | [8] 16, 26, 28, 34, 49, 96, 284, 300 |
| 7 | Amyotrophic lateral sclerosis (ALS) |
[1] TNF | D04687 | Lenalidomide | [8] 16, 26, 28, 34, 49, 96, 284, 300 |
| 8 | Antifolate resistance |
[1] TNF | D04687 | Lenalidomide | [8] 16, 26, 28, 34, 49, 96, 284, 300 |
| 9 | Antigen processing and presentation |
[1] TNF | D04687 | Lenalidomide | [8] 16, 26, 28, 34, 49, 96, 284, 300 |
| 10 | Apoptosis |
[1] TNF | D04687 | Lenalidomide | [8] 16, 26, 28, 34, 49, 96, 284, 300 |
| 11 | Asthma |
[1] TNF | D04687 | Lenalidomide | [8] 16, 26, 28, 34, 49, 96, 284, 300 |
| 12 | Autoimmune thyroid disease |
[2] CD80, CD86 | D03203 | Abatacept | [24] 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
| 13 | C-type lectin receptor signaling pathway |
[1] TNF | D04687 | Lenalidomide | [8] 16, 26, 28, 34, 49, 96, 284, 300 |
| 14 | Cell adhesion molecules (CAMs) |
[2] CD80, CD86 | D03203 | Abatacept | [24] 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
| 15 | Chagas disease (American trypanosomiasis) |
[1] TNF | D04687 | Lenalidomide | [8] 16, 26, 28, 34, 49, 96, 284, 300 |
| 16 | Cytokine-cytokine receptor interaction |
[1] TNF | D04687 | Lenalidomide | [8] 16, 26, 28, 34, 49, 96, 284, 300 |
| 17 | Dilated cardiomyopathy (DCM) |
[1] TNF | D04687 | Lenalidomide | [8] 16, 26, 28, 34, 49, 96, 284, 300 |
| 18 | Drug metabolism - other enzymes |
[2] IMPDH1, IMPDH2 | D00752 | Mycophenolate mofetil | [32] 2, 11, 13, 14, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 85, 95, 96, 162, 164, 222, 224, 226, 234, 283, 284, 285, 300 |
| D05094 | |||||
| D05095 | |||||
| D05096 | Mycophenolic acid | [34] 2, 11, 13, 14, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 84, 85, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300 | |||
| 19 | Epstein-Barr virus infection |
[1] TNF | D04687 | Lenalidomide | [8] 16, 26, 28, 34, 49, 96, 284, 300 |
| 20 | Fc epsilon RI signaling pathway |
[1] TNF | D04687 | Lenalidomide | [8] 16, 26, 28, 34, 49, 96, 284, 300 |
| 21 | Fluid shear stress and atherosclerosis |
[1] TNF | D04687 | Lenalidomide | [8] 16, 26, 28, 34, 49, 96, 284, 300 |
| 22 | Graft-versus-host disease |
[2] CD80, CD86 | D03203 | Abatacept | [24] 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
| [1] TNF | D04687 | Lenalidomide | [8] 16, 26, 28, 34, 49, 96, 284, 300 | ||
| 23 | Hematopoietic cell lineage |
[1] MS4A1 | D02994 | Rituximab | [42] 11, 13, 14, 17, 35, 36, 43, 44, 45, 46, 49, 50, 51, 52, 53, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 223, 229, 256, 271, 283, 284, 285, 288, 300, 331 |
| [1] TNF | D04687 | Lenalidomide | [8] 16, 26, 28, 34, 49, 96, 284, 300 | ||
| 24 | Hepatitis B |
[1] TNF | D04687 | Lenalidomide | [8] 16, 26, 28, 34, 49, 96, 284, 300 |
| 25 | Hepatitis C |
[1] TNF | D04687 | Lenalidomide | [8] 16, 26, 28, 34, 49, 96, 284, 300 |
| 26 | Herpes simplex virus 1 infection |
[1] TNF | D04687 | Lenalidomide | [8] 16, 26, 28, 34, 49, 96, 284, 300 |
| 27 | Human cytomegalovirus infection |
[1] TNF | D04687 | Lenalidomide | [8] 16, 26, 28, 34, 49, 96, 284, 300 |
| 28 | Human immunodeficiency virus 1 infection |
[1] TNF | D04687 | Lenalidomide | [8] 16, 26, 28, 34, 49, 96, 284, 300 |
| 29 | Human papillomavirus infection |
[1] TNF | D04687 | Lenalidomide | [8] 16, 26, 28, 34, 49, 96, 284, 300 |
| 30 | Human T-cell leukemia virus 1 infection |
[1] TNF | D04687 | Lenalidomide | [8] 16, 26, 28, 34, 49, 96, 284, 300 |
| 31 | Hypertrophic cardiomyopathy (HCM) |
[1] TNF | D04687 | Lenalidomide | [8] 16, 26, 28, 34, 49, 96, 284, 300 |
| 32 | IL-17 signaling pathway |
[1] TNF | D04687 | Lenalidomide | [8] 16, 26, 28, 34, 49, 96, 284, 300 |
| 33 | Inflammatory bowel disease (IBD) |
[1] TNF | D04687 | Lenalidomide | [8] 16, 26, 28, 34, 49, 96, 284, 300 |
| 34 | Influenza A |
[1] TNF | D04687 | Lenalidomide | [8] 16, 26, 28, 34, 49, 96, 284, 300 |
| 35 | Insulin resistance |
[1] TNF | D04687 | Lenalidomide | [8] 16, 26, 28, 34, 49, 96, 284, 300 |
| 36 | Intestinal immune network for IgA production |
[2] CD80, CD86 | D03203 | Abatacept | [24] 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
| 37 | Kaposi sarcoma-associated herpesvirus infection |
[1] CD86 | D03203 | Abatacept | [24] 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
| 38 | Legionellosis |
[1] TNF | D04687 | Lenalidomide | [8] 16, 26, 28, 34, 49, 96, 284, 300 |
| 39 | Leishmaniasis |
[1] TNF | D04687 | Lenalidomide | [8] 16, 26, 28, 34, 49, 96, 284, 300 |
| 40 | Malaria |
[1] TNF | D04687 | Lenalidomide | [8] 16, 26, 28, 34, 49, 96, 284, 300 |
| 41 | MAPK signaling pathway |
[1] TNF | D04687 | Lenalidomide | [8] 16, 26, 28, 34, 49, 96, 284, 300 |
| 42 | Metabolic pathways |
[1] DHODH | D00749 | Leflunomide | [10] 11, 40, 46, 49, 53, 66, 162, 224, 271, 300 |
| [2] IMPDH1, IMPDH2 | D00752 | Mycophenolate mofetil | [32] 2, 11, 13, 14, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 85, 95, 96, 162, 164, 222, 224, 226, 234, 283, 284, 285, 300 | ||
| D05094 | |||||
| D05095 | |||||
| D05096 | Mycophenolic acid | [34] 2, 11, 13, 14, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 84, 85, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300 | |||
| 43 | mTOR signaling pathway |
[1] TNF | D04687 | Lenalidomide | [8] 16, 26, 28, 34, 49, 96, 284, 300 |
| 44 | Natural killer cell mediated cytotoxicity |
[1] TNF | D04687 | Lenalidomide | [8] 16, 26, 28, 34, 49, 96, 284, 300 |
| 45 | Necroptosis |
[1] TNF | D04687 | Lenalidomide | [8] 16, 26, 28, 34, 49, 96, 284, 300 |
| 46 | Neuroactive ligand-receptor interaction |
[1] NR3C1 | D00472 | Prednisolone | [38] 11, 13, 25, 26, 35, 38, 39, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 113, 145, 162, 222, 269, 271, 296, 299, 300 |
| D00980 | |||||
| D00981 | |||||
| D00982 | |||||
| D01239 | |||||
| D01998 | |||||
| D02156 | |||||
| D03301 | |||||
| D00473 | Prednisone | [44] 2, 11, 13, 14, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 81, 84, 85, 86, 95, 96, 97, 113, 145, 162, 164, 222, 224, 228, 251, 283, 284, 285, 288, 299, 300, 331 | |||
| 47 | NF-kappa B signaling pathway |
[1] TNF | D04687 | Lenalidomide | [8] 16, 26, 28, 34, 49, 96, 284, 300 |
| 48 | NOD-like receptor signaling pathway |
[1] TNF | D04687 | Lenalidomide | [8] 16, 26, 28, 34, 49, 96, 284, 300 |
| 49 | Non-alcoholic fatty liver disease (NAFLD) |
[1] TNF | D04687 | Lenalidomide | [8] 16, 26, 28, 34, 49, 96, 284, 300 |
| 50 | Osteoclast differentiation |
[1] TNF | D04687 | Lenalidomide | [8] 16, 26, 28, 34, 49, 96, 284, 300 |
| 51 | Pathogenic Escherichia coli infection |
[1] TNF | D04687 | Lenalidomide | [8] 16, 26, 28, 34, 49, 96, 284, 300 |
| 52 | Pertussis |
[1] TNF | D04687 | Lenalidomide | [8] 16, 26, 28, 34, 49, 96, 284, 300 |
| 53 | Proteoglycans in cancer |
[1] TNF | D04687 | Lenalidomide | [8] 16, 26, 28, 34, 49, 96, 284, 300 |
| 54 | Purine metabolism |
[2] IMPDH1, IMPDH2 | D00752 | Mycophenolate mofetil | [32] 2, 11, 13, 14, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 85, 95, 96, 162, 164, 222, 224, 226, 234, 283, 284, 285, 300 |
| D05094 | |||||
| D05095 | |||||
| D05096 | Mycophenolic acid | [34] 2, 11, 13, 14, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 84, 85, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300 | |||
| 55 | Pyrimidine metabolism |
[1] DHODH | D00749 | Leflunomide | [10] 11, 40, 46, 49, 53, 66, 162, 224, 271, 300 |
| 56 | Rheumatoid arthritis |
[2] CD80, CD86 | D03203 | Abatacept | [24] 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
| [1] TNF | D04687 | Lenalidomide | [8] 16, 26, 28, 34, 49, 96, 284, 300 | ||
| 57 | RIG-I-like receptor signaling pathway |
[1] TNF | D04687 | Lenalidomide | [8] 16, 26, 28, 34, 49, 96, 284, 300 |
| 58 | Shigellosis |
[1] TNF | D04687 | Lenalidomide | [8] 16, 26, 28, 34, 49, 96, 284, 300 |
| 59 | Sphingolipid signaling pathway |
[1] TNF | D04687 | Lenalidomide | [8] 16, 26, 28, 34, 49, 96, 284, 300 |
| 60 | Systemic lupus erythematosus |
[2] CD80, CD86 | D03203 | Abatacept | [24] 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
| [1] TNF | D04687 | Lenalidomide | [8] 16, 26, 28, 34, 49, 96, 284, 300 | ||
| 61 | T cell receptor signaling pathway |
[1] TNF | D04687 | Lenalidomide | [8] 16, 26, 28, 34, 49, 96, 284, 300 |
| 62 | TGF-beta signaling pathway |
[1] TNF | D04687 | Lenalidomide | [8] 16, 26, 28, 34, 49, 96, 284, 300 |
| 63 | TNF signaling pathway |
[1] TNF | D04687 | Lenalidomide | [8] 16, 26, 28, 34, 49, 96, 284, 300 |
| 64 | Toll-like receptor signaling pathway |
[2] CD80, CD86 | D03203 | Abatacept | [24] 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
| [1] TNF | D04687 | Lenalidomide | [8] 16, 26, 28, 34, 49, 96, 284, 300 | ||
| 65 | Toxoplasmosis |
[1] TNF | D04687 | Lenalidomide | [8] 16, 26, 28, 34, 49, 96, 284, 300 |
| 66 | Transcriptional misregulation in cancer |
[1] CD86 | D03203 | Abatacept | [24] 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
| 67 | Tuberculosis |
[1] TNF | D04687 | Lenalidomide | [8] 16, 26, 28, 34, 49, 96, 284, 300 |
| 68 | Type I diabetes mellitus |
[2] CD80, CD86 | D03203 | Abatacept | [24] 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
| [1] TNF | D04687 | Lenalidomide | [8] 16, 26, 28, 34, 49, 96, 284, 300 | ||
| 69 | Type II diabetes mellitus |
[1] TNF | D04687 | Lenalidomide | [8] 16, 26, 28, 34, 49, 96, 284, 300 |
| 70 | Viral myocarditis |
[2] CD80, CD86 | D03203 | Abatacept | [24] 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
| 71 | Viral protein interaction with cytokine and cytokine receptor |
[1] TNF | D04687 | Lenalidomide | [8] 16, 26, 28, 34, 49, 96, 284, 300 |
| 72 | Yersinia infection |
[1] TNF | D04687 | Lenalidomide | [8] 16, 26, 28, 34, 49, 96, 284, 300 |